Skeletal Muscle and Platelet Mitochondrial Dysfunction During Sepsis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
European Society of Intensive Care Medicine
Information provided by:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
ClinicalTrials.gov Identifier:
NCT00541827
First received: October 8, 2007
Last updated: February 4, 2010
Last verified: February 2010

October 8, 2007
February 4, 2010
October 2007
October 2010   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00541827 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Skeletal Muscle and Platelet Mitochondrial Dysfunction During Sepsis
Skeletal Muscle and Platelet Mitochondrial Dysfunction During Sepsis.

The primary aim of the study is to demonstrate that mitochondrial dysfunction occurs in both skeletal muscle and circulating platelets of severely septic and septic shock ICU-admitted patients. Secondary aims are to clarify the pathogenesis and the clinical relevance of mitochondrial damage during sepsis.

The primary aim of the study is to demonstrate that mitochondrial dysfunction occurs in both skeletal muscle and circulating platelets of severely septic and septic shock ICU-admitted patients, as compared to otherwise healthy surgical ones. In order to better clarify the pathogenesis of mitochondrial dysfunction during sepsis, cardiogenic shock patients (suffering from systemic hypoperfusion) will act as additional controls. Markers of oxidative stress will be measured in tissue samples from septic patients. The clinical relevance of mitochondrial dysfunction during sepsis will be assessed in terms of both skeletal muscle and platelet function.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

muscle tissue, platelets, plasma

Probability Sample

Adult ICU-admitted severely septic and septic shock patientes; adult ICU-admitted cardiogenic shock patients; surgical patients

  • Severe Sepsis
  • Septic Shock
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
50
October 2010
October 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Consecutive ICU-admitted severely septic or septic shock patients.

Exclusion Criteria:

  • Severe thrombocytopenia.
  • Severe coagulopathy.
  • Pre-existing mitochondrial disease
Both
18 Years and older
Yes
Contact: Luciano Gattinoni, MD 0039.02.5503.3232 gattinon@policlinico.mi.it
Contact: Alessandro Protti, MD 0039.02.5503.3232 alessandro.protti@policlinico.mi.it
Italy
 
NCT00541827
assente
Yes
Luciano Gattinoni, Study Chair, Fondazione Ospedale Maggiore
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
European Society of Intensive Care Medicine
Study Chair: Luciano Gattinoni, MD Ospedale Maggiore Policlinico Mangiagalli e Regina Elena
Principal Investigator: Alessandro Protti, MD Ospedale Maggiore Policlinico Mangiagalli e Regina Elena
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
February 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP